EUVIMEDEUVIMED entdecken
Crossref

BMSCs‐Derived Exosomal XPO7 Attenuates Osteoarthritis Progression by Targeting KDM2B to Ameliorate Chondrocyte Senescence

Xiaodong Mao, Guoliang Che, Mimi Zhang, Xiao Tan, Zhengzhi Liu iD

Journal of Cellular Biochemistry · 2026

DOI: 10.1002/jcb.70130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, 2026. Verfasst von Xiaodong Mao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fifth Department of Orthopedics and Traumatology, Tianxin Campus, Changsha Hospital of Traditional Chinese Medicine, Changsha Eighth Hospital, Changs…. Hauptthemen laut MEDLINE: Chondrocytes, Osteoarthritis, Histone Demethylases, Exosomes. Die Arbeit nennt 40 Literaturangaben. Gefördert von: This study was supported by Natural Science Foundation of Changsha.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chondrocyte senescence is a central driver of osteoarthritis (OA) pathogenesis. While bone marrow mesenchymal stem cell‐derived exosomes (BMSCs‐Exos) exhibit therapeutic potential, their key functional components remain unclear. We therefore investigated whether Exportin‐7 (XPO7), a protein enriched in BMSCs‐Exos, alleviates OA by ameliorating chondrocyte senescence‐associated changes and explores the underlying mechanism. Using an IL‐1β‐induced in vitro OA model in rat chondrocytes, we treated cells with exosomes from BMSCs with modulated XPO7 overexpression or knockdown; KDM2B was overexpressed in chondrocytes. Senescence, apoptosis, viability, senescence‐associated secretory phenotype (SASP) markers, and extracellular matrix (ECM) metabolism were evaluated. We found that BMSCs‐Exos significantly mitigated IL‐1β‐induced chondrocyte senescence‐like changes, apoptosis, SASP (p16, p21, p53, IL‐1β, IL‐6, TNF‐α), and ECM degradation, as evidenced by the reversal of IL‐1β‐induced suppression of anabolic genes SOX9, COL2, ACAN and elevated catabolic gene MMP13. These protective effects were enhanced by XPO7 overexpression and diminished by its knockdown. Co‐immunoprecipitation and immunofluorescence further showed that XPO7 physically interacted with and negatively regulated the histone demethylase KDM2B, and overexpressing KDM2B abolished the protective effects of XPO7‐enriched exosomes. In an in vivo rat OA model induced by anterior cruciate ligament transection (ACLT), systemic administration of BMSCs‐Exos overexpressing XPO7 attenuated cartilage destruction and improved mechanical allodynia (increased paw withdrawal threshold). These therapeutic benefits were significantly reversed by concurrent intra‐articular injection with a KDM2B overexpressing plasmid. Collectively, BMSCs‐Exos deliver XPO7, which negatively regulates KDM2B to attenuate chondrocyte senescence‐associated phenotypes and OA progression. The XPO7‐KDM2B axis may represent a promising therapeutic target for OA intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesOsteoarthritisHistone DemethylasesExosomesMesenchymal Stem CellsInterleukin-1betaAnimalsRatsRats, Sprague-DawleyApoptosis

Stichwörter der Autor:innen

KDM2BXPO7bone marrow mesenchymal stem cell‐derived exosomescellular senescenceosteoarthritis

Substanzen

Interleukin-1betaHistone Demethylases

Autor:innen und Institutionen

  • Fifth Department of Orthopedics and Traumatology, Tianxin Campus, Changsha Hospital of Traditional Chinese Medicine, Changsha Eighth Hospital, Changsha, China.
  • Fourth Department of Orthopedics and Traumatology, Tianxin Campus, Changsha Hospital of Traditional Chinese Medicine, Changsha Eighth Hospital, Changsha, China.

ORCID-Profile: Zhengzhi Liu

Förderung

  • This study was supported by Natural Science Foundation of Changsha

Zitieren

APA

Mao, X., Che, G., Zhang, M., Tan, X., & Liu, Z. (2026). BMSCs‐Derived Exosomal XPO7 Attenuates Osteoarthritis Progression by Targeting KDM2B to Ameliorate Chondrocyte Senescence. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.70130

Vancouver

Mao X, Che G, Zhang M, Tan X, Liu Z. BMSCs‐Derived Exosomal XPO7 Attenuates Osteoarthritis Progression by Targeting KDM2B to Ameliorate Chondrocyte Senescence. Journal of Cellular Biochemistry. 2026. doi:10.1002/jcb.70130

BibTeX
@article{Mao2026,
  author = {Mao, Xiaodong and Che, Guoliang and Zhang, Mimi and Tan, Xiao and Liu, Zhengzhi},
  title = {BMSCs‐Derived Exosomal XPO7 Attenuates Osteoarthritis Progression by Targeting KDM2B to Ameliorate Chondrocyte Senescence},
  journal = {Journal of Cellular Biochemistry},
  year = {2026},
  doi = {10.1002/jcb.70130}
}
Kostenlos starten →